Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding

Yu Hwee Tan, Amita A Singla, Anne Lethaby, Martin C Sowter
In: Cochrane Database of Systematic Reviews · 2012 · doi:10.1002/14651858.cd010241 · W4233970191
Other OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This protocol outlines a Cochrane Review to assess the effectiveness and safety of pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding in pre-menopausal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effectiveness and safety of pre‐operative endometrial thinning agents (GnRH agonists, danazol, estrogen‐progestin contraceptives and progestogens) versus another agent or versus placebo before endometrial destruction in pre‐menstrual women with heavy menstrual bleeding.

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (32)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T18:10:43.271597+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0 · commercial use OK